Biopharma · FDA Approvals · Stock
CYRX CryoPort
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic …
Catalyst calendar
Dated catalysts for CYRX, including recently decided ones.
Nothing scheduled in this window.
Recent first-hand events
Every first-hand event for CYRX, newest first.
Instant stream — events appear as soon as they are filed.
Decision-gradeMaterialNotableMinor
No events yet.
Peers by market cap
Companies in the same sector closest to CYRX in market value.
ALMSAlumisMarket cap $871.1M · 1 tracked drug · 2 upcoming catalysts
VSTMVerastemMarket cap $883.0M · 3 tracked drugs · 26 upcoming catalysts
IVAInventivaMarket cap $862.3M · 1 tracked drug · 1 upcoming catalyst
PRMEPrime MedicineMarket cap $856.1M · 2 tracked drugs · 2 upcoming catalysts
TBPHTheravance BiopharmaMarket cap $855.8M · 2 tracked drugs
MGTXMeiraGTxMarket cap $911.4M · 1 tracked drug
KURAKura OncologyMarket cap $912.7M · 1 tracked drug · 5 upcoming catalystsOOBXObsidian TherapeuticsMarket cap $913.6M · 1 tracked drug · 2 upcoming catalysts